Earnings Call · Q1 FY2026·2026-04-22

Q1 26EPS +38.96%·Rev n/aQ4 25EPS +16.67%·Rev n/aQ3 25EPS +21.43%·Rev n/aQ2 25EPS +47.06%·Rev n/a⚠ consensus missing

Amneal Pharmaceuticals, Inc. AMRX

Anthony DiMeo — Head of Investor Relations

Chirag Patel — President & Co-CEO

Chintu Patel — Co-CEO

Anastasios Konidaris — CFO

−1.5%1d on move date−2.5% vs SPY3d−3.8%5d−2.2%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AMRX calls or request research access.

More AMRX calls Browse calls Request research access